News headlines about Vascular Solutions (NASDAQ:VASC) have trended somewhat negative recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Vascular Solutions earned a daily sentiment score of -0.16 on Accern’s scale. Accern also assigned news stories about the medical device company an impact score of 25 out of 100, meaning that recent news coverage is very unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the news stories that may have impacted Accern’s scoring:

Shares of Vascular Solutions (VASC) remained flat at $56.00 on Friday. Vascular Solutions has a 52 week low of $25.06 and a 52 week high of $57.15. The company’s 50-day moving average is $55.89 and its 200 day moving average is $51.22.

ILLEGAL ACTIVITY WARNING: “Somewhat Critical Press Coverage Very Unlikely to Affect Vascular Solutions (NASDAQ:VASC) Stock Price” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at

Vascular Solutions Company Profile

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Insider Buying and Selling by Quarter for Vascular Solutions (NASDAQ:VASC)

Receive News & Stock Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related stocks with our FREE daily email newsletter.